LAST PRODUCTS VIEWED
RELATED PRODUCT TAGS
HercepTest™ is a semi-quantitative immunohistochemical assay for determination of HER2 protein (c-erbB-2 oncoprotein) overexpression in breast cancer tissues routinely processed for histological evaluation and formalin-fixed, paraffin-embedded cancer tissue from patients with metastatic gastric or gastroesophageal junction adenocarcinoma. HercepTest™ specifically demonstrates overexpression of HER2 protein. HercepTest™ is indicated as an aid in the assessment of breast and gastric cancer patients for whom Herceptin® (trastuzumab) treatment is being considered and for breast cancer patients for whom PERJETA™ (pertuzumab) or KADCYLA™ (ado-trastuzumab emtansine) treatment is being considered (see Herceptin®, PERJETA™, and KADCYLA™ package inserts).
HercepTest™, Herceptin®, PERJETA™, and KADCYLA™are trademarks owned by Genentech, Inc. and/or F. Hoffmann-La Roche Ltd.; HercepTest™ is subject to an exclusive trademark license to Dako Denmark A/S.
Disclaimer: Due to variances among color computer monitors, the colors you see on your screen may not be the exact colors of the stain. The image you see should be considered close renditions to the actual stain.
HER2, ERBB2, c-erbB-2